Loading...
Pharmagreen Biotech Inc.
PHBI•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.001
$-0.00(-11.11%)
Pharmagreen Biotech Inc. (PHBI) Financial Performance & Income Statement Overview
Review Pharmagreen Biotech Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.74%
↑ 13.74%
Operating Income Growth
47.64%
↑ 47.64%
Net Income Growth
-76.59%
↓ 76.59%
Operating Cash Flow Growth
61.96%
↑ 61.96%
Operating Margin
-7807.79%
↓ 7807.79%
Gross Margin
44.84%
↑ 44.84%
Net Profit Margin
-7536.88%
↓ 7536.88%
ROE
9.06%
↑ 9.06%
ROIC
10.15%
↑ 10.15%
Pharmagreen Biotech Inc. (PHBI) Income Statement & Financial Overview
Review Pharmagreen Biotech Inc.'s (PHBI) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $906.00 | $276.00 | $246.00 | $560.00 |
| Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Cash & Short Term Investments | $906.00 | $276.00 | $246.00 | $560.00 |
| Net Receivables | $567.00 | $585.00 | $576.00 | $583.00 |
| Inventory | $7839.00 | $7970.00 | $8249.00 | $8403.00 |
| Other Current Assets | $88850.00 | $0.00 | $0.00 | $5414.00 |
| Total Current Assets | $98162.00 | $8831.00 | $9071.00 | $14960.00 |
| Property Plant & Equipment (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill & Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Long Term Investments | $0.00 | $0.00 | $88850.00 | $88850.00 |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $0.00 | $88850.00 | $0.00 | $0.00 |
| Total Non-Current Assets | $0.00 | $88850.00 | $88850.00 | $88850.00 |
| Total Assets | $98162.00 | $97681.00 | $97921.00 | $103810.00 |
| Account Payables | $788907.00 | $799705.00 | $795493.00 | $783185.00 |
| Short Term Debt | $264083.00 | $265529.00 | $264696.00 | $264728.00 |
| Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Liabilities | $1.35M | $2.08M | $1.28M | $1.27M |
| Total Current Liabilities | $2.41M | $3.14M | $2.34M | $2.32M |
| Long Term Debt | $88327.00 | $90714.00 | $90148.00 | $90632.00 |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Liabilities | $88327.00 | $90714.00 | $90148.00 | $90631.00 |
| Capital Lease Obligations | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $2.50M | $3.23M | $2.43M | $2.41M |
| Preferred Stock | $10.00 | $10.00 | $10.00 | $10.00 |
| Common Stock | $663646.00 | $663646.00 | $663646.00 | $663646.00 |
| Retained Earnings | -$13.51M | -$14.15M | -$13.37M | -$13.33M |
| Accumulated Other Comprehensive Income/Loss | $179861.00 | $76520.00 | $100456.00 | $80839.00 |
| Total Stockholders Equity | -$2.35M | -$3.09M | -$2.28M | -$2.26M |
| Total Equity | -$2.40M | -$3.13M | -$2.33M | -$2.31M |
| Total Liabilities & Stockholders Equity | $98162.00 | $97681.00 | $97921.00 | $103810.00 |
| Total Investments | $0.00 | $0.00 | $88850.00 | $88850.00 |
| Total Debt | $352410.00 | $356243.00 | $354844.00 | $355360.00 |
| Net Debt | $351504.00 | $355967.00 | $354598.00 | $354800.00 |
Pharmagreen Biotech Inc. (PHBI) Balance Sheet Analysis
Pharmagreen Biotech Inc. (PHBI) manages its money wisely, with plenty of 61.96% and -76.59% to cover its bills. The company’s long-term debts are N/A, balanced by steady -7536.88%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan